Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025)
Akari Therapeutics' (AKTX) quarterly Exchange Rate Effect came in at -$3000.0 in Q3 2025, down 250.0% year-on-year from $2000.0 in Q3 2024, and down 400.0% quarter-over-quarter from $1000.0 in Q4 2024.
Akari Therapeutics (AKTX) Exchange Rate Effect (2014 - 2025) Analysis & Trends
Akari Therapeutics has disclosed Exchange Rate Effect across 8 years of filings, most recently posting -$3000.0 for Q3 2025.
- Exchange Rate Effect for Q3 2025 came in at -$3000.0, down 250.0% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2000.0 (down 300.0% YoY), and the FY2025 annual result was $1000.0, up 125.0% from the prior year.
- Exchange Rate Effect came in at -$3000.0 for Q3 2025 at Akari Therapeutics, down from $1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $6000.0 in Q4 2023 to a low of -$5000.0 in Q1 2024.
- The 3-year median for Exchange Rate Effect is -$1000.0 (2023), against an average of -$285.71.
- Across the five-year window, Exchange Rate Effect jumped 300.0% in 2024 and sank 250.0% in 2025, its largest moves.
- Akari Therapeutics' Exchange Rate Effect stood at $6000.0 in 2023, then plunged by 83.33% to $1000.0 in 2024, then plunged by 400.0% to -$3000.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$3000.0 (Q3 2025), $1000.0 (Q4 2024), and $2000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Dec 31, 2023 | 6,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2020 | -21,401.00 |
| Dec 31, 2020 | -21,401.00 |
| Sep 30, 2020 | 275,701.00 |
| Sep 30, 2020 | 275,701.00 |
| Jun 30, 2020 | -5,924.00 |
| Jun 30, 2020 | -5,924.00 |